Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
34732 | 64 | 31.0 | 64% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2282 | 4190 | INTERSTITIAL CYSTITIS//CYSTITIS INTERSTITIAL//PAINFUL BLADDER SYNDROME |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | EGLETES VISCOSA | Author keyword | 27 | 92% | 17% | 11 |
2 | AUXEMMA ONCOCALYX | Author keyword | 17 | 100% | 13% | 8 |
3 | ONCOCALYXONE A | Author keyword | 12 | 86% | 9% | 6 |
4 | TETRAMETHOXYFLAVONE | Author keyword | 3 | 60% | 5% | 3 |
5 | TERNATIN | Author keyword | 2 | 38% | 8% | 5 |
6 | AUXEMMA GLAZIOVIANA | Author keyword | 1 | 100% | 3% | 2 |
7 | EGLETES VISCOSA L | Author keyword | 1 | 100% | 3% | 2 |
8 | FERMENTED GRAPE MARC | Author keyword | 1 | 100% | 3% | 2 |
9 | ONCOCALYXONE | Author keyword | 1 | 100% | 3% | 2 |
10 | ONCOCALYXONES | Author keyword | 1 | 100% | 3% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | EGLETES VISCOSA | 27 | 92% | 17% | 11 | Search EGLETES+VISCOSA | Search EGLETES+VISCOSA |
2 | AUXEMMA ONCOCALYX | 17 | 100% | 13% | 8 | Search AUXEMMA+ONCOCALYX | Search AUXEMMA+ONCOCALYX |
3 | ONCOCALYXONE A | 12 | 86% | 9% | 6 | Search ONCOCALYXONE+A | Search ONCOCALYXONE+A |
4 | TETRAMETHOXYFLAVONE | 3 | 60% | 5% | 3 | Search TETRAMETHOXYFLAVONE | Search TETRAMETHOXYFLAVONE |
5 | TERNATIN | 2 | 38% | 8% | 5 | Search TERNATIN | Search TERNATIN |
6 | AUXEMMA GLAZIOVIANA | 1 | 100% | 3% | 2 | Search AUXEMMA+GLAZIOVIANA | Search AUXEMMA+GLAZIOVIANA |
7 | EGLETES VISCOSA L | 1 | 100% | 3% | 2 | Search EGLETES+VISCOSA+L | Search EGLETES+VISCOSA+L |
8 | FERMENTED GRAPE MARC | 1 | 100% | 3% | 2 | Search FERMENTED+GRAPE+MARC | Search FERMENTED+GRAPE+MARC |
9 | ONCOCALYXONE | 1 | 100% | 3% | 2 | Search ONCOCALYXONE | Search ONCOCALYXONE |
10 | ONCOCALYXONES | 1 | 100% | 3% | 2 | Search ONCOCALYXONES | Search ONCOCALYXONES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CORDIACHROMES | 15 | 77% | 16% | 10 |
2 | AUXEMMA ONCOCALYX | 11 | 78% | 11% | 7 |
3 | QUINONE FRACTION | 6 | 100% | 6% | 4 |
4 | TETRAMETHOXYFLAVONE | 6 | 100% | 6% | 4 |
5 | TERNATIN | 4 | 41% | 11% | 7 |
6 | EGLETES VISCOSA LESS | 1 | 40% | 3% | 2 |
7 | EGLETES VISCOSA | 1 | 50% | 2% | 1 |
8 | FERMENTED GRAPE MARC | 1 | 50% | 2% | 1 |
9 | IRONIII TETRA N METHYL 4 PYRIDYL PORPHYRIN | 1 | 50% | 2% | 1 |
10 | ONCOCALYX | 1 | 50% | 2% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The FDA critical path initiative and its influence on new drug development | 2008 | 138 | 7 | 14% |
Fermented Grape Marc (FGM): Immunomodulating Properties and its Potential Exploitation in the Treatment of Neurodegenerative Diseases | 2012 | 10 | 28 | 18% |
Immunopathogenesis of Neurodegenerative Diseases: Current Therapeutic Models of Neuroprotection with Special Reference to Natural Products | 2012 | 19 | 122 | 4% |
The drug development crisis: Efficiency and safety | 2007 | 20 | 39 | 3% |
Elicitation of Immune Responsiveness Against Antigenic Challenge in Age- Related Diseases: Effects of Red Wine Polyphenols | 2008 | 13 | 49 | 2% |
Molecular Effects Elicited In Vitro by Red Wine on Human Healthy Peripheral Blood Mononuclear Cells: Potential Therapeutical Application of Polyphenols to Diet-Related Chronic Diseases | 2008 | 10 | 48 | 2% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ADV MAT CHEM GRP GQMAT | 1 | 50% | 1.6% | 1 |
2 | NACL CIENCIA TECNOL INCT | 1 | 50% | 1.6% | 1 |
3 | FFOE | 0 | 25% | 1.6% | 1 |
4 | PROD PROC TECHNOL LPT | 0 | 25% | 1.6% | 1 |
5 | BIOMOL S | 0 | 11% | 3.1% | 2 |
6 | HUMAN HOOKWORM VACCINE INITIAT | 0 | 13% | 1.6% | 1 |
7 | SETOR PROD NAT | 0 | 13% | 1.6% | 1 |
8 | SUPER BIOMED | 0 | 11% | 1.6% | 1 |
9 | TABULEIRO MARTINS | 0 | 11% | 1.6% | 1 |
10 | DISCOVERY PERFORMANCE UNIT NEURONAL TARGETS | 0 | 100% | 1.6% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000233717 | UROTOXICITY//HEMORRHAGIC CYSTITIS//PECAN NUT SHELLS |
2 | 0.0000147867 | CORDIA VERBENACEA//CORDIA PIAUHIENSIS//CORDIAQUINONES |
3 | 0.0000123522 | ANTIDIARRHOEAL ACTIVITY//ZALDARIDE MALEATE//CARPOLOBIA LUTEA |
4 | 0.0000114672 | POLYPODIUM LEUCOTOMOS//AMBURANA CEARENSIS//POLYPODIUM DECUMANUM |
5 | 0.0000099950 | MODIFYING ANTIBIOTIC ACTIVITY//MODIFICATION OF RESISTANCE//GENET MICRORGANISMS |
6 | 0.0000092478 | SOLARE ENERGIETECH//PHOTOACYLATION//REACTIONS AND METHODS |
7 | 0.0000084008 | PROGRAM LIFE SCI ETH POLICY//MCLAUGHLIN ROTMAN GLOBAL HLTH//ESRC INNOGEN |
8 | 0.0000083307 | CLINICAL TRIAL RISK//CONTINUOUS IMPROVEMENT//STRATEGIE IND |
9 | 0.0000076145 | GAULTHERIA YUNNANENSIS//METHYL SALICYLATE 2 O BETA D LACTOSIDE//GAULTHERIN |
10 | 0.0000075969 | FRE 2370//PICTORIAL HISTORY//FRE 2730 |